Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological

Repeated Administration of 2-Hydroxypropyl-β-Cyclodextrin (HPβCD) Attenuates the Chronic Inflammatory Response to Experimental Stroke

Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease

Monitoring the itinerary of lysosomal cholesterol in Niemann-Pick Type C1-deficient cells after cyclodextrin treatment - ScienceDirect

Predicting the Binding Mode of 2-Hydroxypropyl-β-cyclodextrin to Cholesterol by Means of the MD Simulation and the 3D-RISM-KH Theory

Frontiers The Effects of Combined Therapy With Metformin and Hydroxypropyl -β-Cyclodextrin in a Mouse Model of Niemann-Pick Disease Type C1

Biomolecules, Free Full-Text

Longitudinal Data in Patients with Niemann-Pick Type C Disease Under Combined High Intrathecal and Low Intravenous Dose of 2-hydroxylpropyl-β- cyclodextrin - Innovations in Clinical Neuroscience

Frontiers The Effects of Combined Therapy With Metformin and Hydroxypropyl -β-Cyclodextrin in a Mouse Model of Niemann-Pick Disease Type C1

Biomolecules, Free Full-Text

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet

Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation